The cost hike of the antidepressant, first reported on April 3, sets the price of a 120-milliliter bottle at $67.
The company also raised the price of a generic version of Vicodin and haloperidol, a schizophrenia treatment, by more than 100 percent, according to the report.
While triple-digit price hikes are not illegal, they are a rebuke of a common industry practice of keeping price increases below 10 percent annually.
Read the full report here.
More articles on pharmacy:
7 drugs projected to become blockbusters by 2023
3 insulin manufacturers to testify at House panel April 10
Cigna-Express Scripts cap out-of-pocket 30-day insulin costs at $25
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
